Provided by Tiger Trade Technology Pte. Ltd.

Anaptysbio Inc

58.44
+0.70001.21%
Post-market: 57.51-0.9300-1.59%19:30 EDT
Volume:627.05K
Turnover:36.45M
Market Cap:1.73B
PE:-64.60
High:59.07
Open:56.96
Low:55.57
Close:57.74
52wk High:73.30
52wk Low:17.11
Shares:29.61M
Float Shares:21.05M
Volume Ratio:2.11
T/O Rate:2.98%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9047
EPS(LYR):-0.4601
ROE:-114.55%
ROA:6.78%
PB:135.74
PE(LYR):-127.01

Loading ...

Anaptys Completes Separation of First Tracks Biotherapeutics and NOW Exclusively Manages GSK and Vanda Financial Collaborations

THOMSON REUTERS
·
Apr 20

AnaptysBio completes spin-off of First Tracks Biotherapeutics in corporate reorganization

Reuters
·
Apr 20

Trade Alert: Independent Director Of AnaptysBio John Schmid Has Sold Stock

Simply Wall St.
·
Apr 08

Assessing AnaptysBio (ANAB) Valuation After New Share Buyback Plan And Canceled Equity Offering

Simply Wall St.
·
Apr 06

Analysts Conflicted on These Healthcare Names: Neumora Therapeutics, Inc. (NMRA), Palisade Bio (PALI) and AnaptysBio (ANAB)

TIPRANKS
·
Apr 04

AnaptysBio files Form 3 for director Susannah Gray, reporting no securities owned

Reuters
·
Apr 04

AnaptysBio director John P. Schmid disposes shares worth $1.1 million

Reuters
·
Apr 02

AnaptysBio Is Maintained at Overweight by Piper Sandler

Dow Jones
·
Apr 01

U.S. RESEARCH ROUNDUP-Dutch Bros, Phreesia, Starbucks

Reuters
·
Mar 31

AnaptysBio Price Target Maintained With a $66.00/Share by HC Wainwright & Co.

Dow Jones
·
Mar 30

AnaptysBio Spin Off Reshapes Risk Profile With New Royalty Focus

Simply Wall St.
·
Mar 30

BUZZ-U.S. STOCKS ON THE MOVE-Entergy, IDEX Corp, Quanta Services

Reuters
·
Mar 27

BUZZ-AnaptysBio falls after board approves First Tracks Biotherapeutics spinoff

Reuters
·
Mar 27

AnaptysBio announces $100M share repurchase program

TIPRANKS
·
Mar 27

AnaptysBio; First Tracks Bio private placement raises $80 million at $13.81 per share

Reuters
·
Mar 27

BRIEF-Anaptys Announces $100 Million Stock Repurchase Plan And Provides A Business Update

Reuters
·
Mar 27

BRIEF-Anaptys Board Of Directors Approves Spin-Off Of First Tracks Biotherapeutics

Reuters
·
Mar 27

BRIEF-First Tracks Biotherapeutics, The Planned Spin-Off Of Anaptys, Secures Commitments Of $145 Million In Private Placement

Reuters
·
Mar 27

AnaptysBio authorizes $100.0 million stock repurchase plan; program expires Dec. 31, 2026

Reuters
·
Mar 27

AnaptysBio Inc: Search Initiated for a CFO for Anaptys Post the Spin-off of First Tracks Bio

THOMSON REUTERS
·
Mar 27